Intuitive Surgical Inkomsten in het verleden
Verleden criteriumcontroles 5/6
Intuitive Surgical is de winst gegroeid met een gemiddeld jaarlijks percentage van 9.8%, terwijl de Medical Equipment industrie de winst jaarlijks groeide met 13.3%. De inkomsten zijn gegroeid met een gemiddelde snelheid van 13% per jaar. Het rendement op eigen vermogen van Intuitive Surgical is 14.4%, en het heeft een nettomarge van 28.5%.
Belangrijke informatie
9.8%
Groei van de winst
9.5%
Groei van de winst per aandeel
| Medical Equipment Groei van de industrie | 8.9% |
| Inkomstengroei | 13.0% |
| Rendement op eigen vermogen | 14.4% |
| Nettomarge | 28.5% |
| Laatste winstupdate | 30 Sep 2024 |
Recente prestatie-updates uit het verleden
There May Be Underlying Issues With The Quality Of Intuitive Surgical's (NASDAQ:ISRG) Earnings
Jul 26
Recent updates
Intuitive Surgical Q3: Da Vinci 5 Robot Set For 2025, But Overvalued
Oct 18Intuitive Surgical (NASDAQ:ISRG) Is Reinvesting At Lower Rates Of Return
Oct 04Intuitive Surgical Offers Low Risk, High Return Despite Valuation Concerns
Sep 24What You Can Learn From Intuitive Surgical, Inc.'s (NASDAQ:ISRG) P/S
Sep 16Intuitive Surgical: Detached From Fundamentals
Aug 26Intuitive Surgical: A Lofty Price To Pay For Innovation, Wait For A Better Entry Point
Aug 20There May Be Underlying Issues With The Quality Of Intuitive Surgical's (NASDAQ:ISRG) Earnings
Jul 26Intuitive Surgical: Shares Surge, But Now Near Fair Value (Rating Downgrade)
Jul 12Does Intuitive Surgical (NASDAQ:ISRG) Deserve A Spot On Your Watchlist?
Jul 11There Are Reasons To Feel Uneasy About Intuitive Surgical's (NASDAQ:ISRG) Returns On Capital
Jun 25What Is Intuitive Surgical, Inc.'s (NASDAQ:ISRG) Share Price Doing?
Jun 10Intuitive Surgical: Sell Signals Abound
May 17Intuitive Surgical, Inc.'s (NASDAQ:ISRG) CEO Compensation Looks Acceptable To Us And Here's Why
Apr 19Intuitive Surgical: Growth And Margins Will Be Challenged In 2024
Apr 12Intuitive Surgical (NASDAQ:ISRG) Will Want To Turn Around Its Return Trends
Mar 27Is It Too Late To Consider Buying Intuitive Surgical, Inc. (NASDAQ:ISRG)?
Mar 11Intuitive Surgical, Inc.'s (NASDAQ:ISRG) Earnings Haven't Escaped The Attention Of Investors
Feb 09Intuitive Surgical: Buy A 'Little Slice' Of The Future
Jan 29Do Intuitive Surgical's (NASDAQ:ISRG) Earnings Warrant Your Attention?
Jan 25Intuitive Surgical: Strong Pre-Announced Q4 - Time To Harvest The Gain, Initiate With 'Sell'
Jan 13Some Investors May Be Worried About Intuitive Surgical's (NASDAQ:ISRG) Returns On Capital
Dec 10At US$318, Is Intuitive Surgical, Inc. (NASDAQ:ISRG) Worth Looking At Closely?
Nov 25Should You Be Adding Intuitive Surgical (NASDAQ:ISRG) To Your Watchlist Today?
Oct 25Are Intuitive Surgical, Inc. (NASDAQ:ISRG) Investors Paying Above The Intrinsic Value?
Sep 22What Does Intuitive Surgical, Inc.'s (NASDAQ:ISRG) Share Price Indicate?
Aug 04There Are Reasons To Feel Uneasy About Intuitive Surgical's (NASDAQ:ISRG) Returns On Capital
Jul 17Intuitive Surgical (NASDAQ:ISRG) Might Be Having Difficulty Using Its Capital Effectively
Apr 08Is There Now An Opportunity In Intuitive Surgical, Inc. (NASDAQ:ISRG)?
Jan 26There Are Reasons To Feel Uneasy About Intuitive Surgical's (NASDAQ:ISRG) Returns On Capital
Jan 08Is Intuitive Surgical, Inc. (NASDAQ:ISRG) Worth US$272 Based On Its Intrinsic Value?
Dec 03Intuitive Surgical: Risky Ahead Of Q3 Earnings
Oct 16Is It Too Late To Consider Buying Intuitive Surgical, Inc. (NASDAQ:ISRG)?
Oct 11Japanese regulatory agency clears Intuitive's single-port robotic surgical system
Sep 30Returns On Capital At Intuitive Surgical (NASDAQ:ISRG) Paint A Concerning Picture
Sep 26Intuitive Surgical: Fundamentally Fairly Valued, Technically Risky (Technical Analysis)
Sep 23Intuitive Surgical: Raising The Red Flag On The Hospital Industry
Aug 23Estimating The Intrinsic Value Of Intuitive Surgical, Inc. (NASDAQ:ISRG)
Jul 26Intuitive Surgical to report Q2 result amid persistent COVID-19 headwinds
Jul 20Should You Think About Buying Intuitive Surgical, Inc. (NASDAQ:ISRG) Now?
Jul 11Intuitive Surgical: Quite Invasive
Jul 06Returns On Capital Signal Tricky Times Ahead For Intuitive Surgical (NASDAQ:ISRG)
Jun 27Intuitive Surgical Is Getting Close To Fair Value After Years Of Overvaluation
Jun 20With EPS Growth And More, Intuitive Surgical (NASDAQ:ISRG) Is Interesting
Jun 13Opbrengsten en kosten
Opbrengsten en kosten
Hoe Intuitive Surgical geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Sep 24 | 7,867 | 2,243 | 2,095 | 1,111 |
| 30 Jun 24 | 7,573 | 2,094 | 2,036 | 1,074 |
| 31 Mar 24 | 7,319 | 1,988 | 1,975 | 1,038 |
| 31 Dec 23 | 7,124 | 1,798 | 1,964 | 999 |
| 30 Sep 23 | 6,851 | 1,517 | 1,863 | 983 |
| 30 Jun 23 | 6,665 | 1,425 | 1,847 | 951 |
| 31 Mar 23 | 6,431 | 1,312 | 1,801 | 913 |
| 31 Dec 22 | 6,222 | 1,322 | 1,712 | 879 |
| 30 Sep 22 | 6,118 | 1,378 | 1,673 | 818 |
| 30 Jun 22 | 5,964 | 1,435 | 1,600 | 767 |
| 31 Mar 22 | 5,906 | 1,644 | 1,532 | 722 |
| 31 Dec 21 | 5,710 | 1,705 | 1,467 | 671 |
| 30 Sep 21 | 5,489 | 1,689 | 1,370 | 637 |
| 30 Jun 21 | 5,163 | 1,623 | 1,305 | 627 |
| 31 Mar 21 | 4,551 | 1,173 | 1,234 | 608 |
| 31 Dec 20 | 4,358 | 1,061 | 1,216 | 595 |
| 30 Sep 20 | 4,307 | 1,053 | 1,227 | 602 |
| 30 Jun 20 | 4,358 | 1,136 | 1,220 | 583 |
| 31 Mar 20 | 4,604 | 1,386 | 1,213 | 560 |
| 31 Dec 19 | 4,479 | 1,379 | 1,178 | 557 |
| 30 Sep 19 | 4,247 | 1,314 | 1,121 | 521 |
| 30 Jun 19 | 4,040 | 1,210 | 1,053 | 492 |
| 31 Mar 19 | 3,850 | 1,147 | 998 | 467 |
| 31 Dec 18 | 3,724 | 1,128 | 941 | 418 |
| 30 Sep 18 | 3,570 | 804 | 876 | 385 |
| 30 Jun 18 | 3,457 | 810 | 847 | 361 |
| 31 Mar 18 | 3,306 | 778 | 820 | 351 |
| 31 Dec 17 | 3,138 | 671 | 811 | 329 |
| 30 Sep 17 | 3,003 | 906 | 762 | 311 |
| 30 Jun 17 | 2,878 | 819 | 736 | 290 |
| 31 Mar 17 | 2,790 | 780 | 712 | 260 |
| 31 Dec 16 | 2,707 | 738 | 692 | 240 |
| 30 Sep 16 | 2,619 | 722 | 666 | 223 |
| 30 Jun 16 | 2,522 | 678 | 653 | 212 |
| 31 Mar 16 | 2,434 | 628 | 643 | 206 |
| 31 Dec 15 | 2,367 | 589 | 627 | 197 |
| 30 Sep 15 | 2,285 | 546 | 621 | 192 |
| 30 Jun 15 | 2,250 | 502 | 620 | 189 |
| 31 Mar 15 | 2,179 | 472 | 615 | 179 |
| 31 Dec 14 | 2,132 | 419 | 609 | 178 |
| 30 Sep 14 | 2,082 | 438 | 602 | 172 |
| 30 Jun 14 | 2,031 | 471 | 587 | 168 |
| 31 Mar 14 | 2,097 | 526 | 581 | 169 |
| 31 Dec 13 | 2,244 | 671 | 574 | 168 |
Kwaliteitswinsten: ISRG heeft hoge kwaliteitsinkomsten.
Groeiende winstmarge: De huidige netto winstmarges (28.5%) ISRG } zijn hoger dan vorig jaar (22.1%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: De winst van ISRG is de afgelopen 5 jaar met 9.8% per jaar gegroeid.
Versnelling van de groei: De winstgroei van ISRG over het afgelopen jaar ( 47.9% ) overtreft het 5-jarig gemiddelde ( 9.8% per jaar).
Winst versus industrie: De winstgroei ISRG over het afgelopen jaar ( 47.9% ) overtrof de Medical Equipment -sector 12.2%.
Rendement op eigen vermogen
Hoge ROE: Het Rendement op eigen vermogen ( 14.4% ) van ISRG wordt als laag beschouwd.